Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Boris Lams

Showing results (11-20 of 16) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 16 results.
BJA Open|February 6, 2023
Steroid exposure and outcome in COVID-19 pneumoniaChristopher Remmington, Nicholas A Barrett, Sangita Agarwal, et al.
The Lancet. Rheumatology|May 4, 2026
Anti-MDA5-associated rapidly progressive-ILD-the intersection of hyperinflammation and fibrosisPuja Mehta, Deepthi Joy, Marium Naqvi, et al.
Rheumatology (Oxford, England)|February 1, 2022
Rheumatologists have an important role in the management of interstitial lung disease (ILD): a cross-speciality, multi-centre, UK perspectivePuja Mehta, Rachel K Hoyles, Harsha Gunawardena, et al.
The Lancet. Respiratory Medicine|February 22, 2021
Delayed-onset myocarditis following COVID-19Retesh Bajaj, Hannah C Sinclair, Kush Patel, et al.
Rheumatology (Oxford, England)|December 1, 2023
Antibody predictors of mortality and lung function trends in myositis spectrum interstitial lung diseaseJennifer R Hannah, Alexandra Lawrence, Jennifer Martinovic, et al.
The Lancet. Respiratory Medicine|March 30, 2020
The role of CT in case ascertainment and management of COVID-19 pneumonia in the UK: insights from high-incidence regionsFelix Chua, Darius Armstrong-James, Sujal R Desai, et al.
Pageof 2

Showing results (11-20 of 16) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 16 results.
BJA Open|February 6, 2023
Steroid exposure and outcome in COVID-19 pneumoniaChristopher Remmington, Nicholas A Barrett, Sangita Agarwal, et al.
The Lancet. Rheumatology|May 4, 2026
Anti-MDA5-associated rapidly progressive-ILD-the intersection of hyperinflammation and fibrosisPuja Mehta, Deepthi Joy, Marium Naqvi, et al.
Rheumatology (Oxford, England)|February 1, 2022
Rheumatologists have an important role in the management of interstitial lung disease (ILD): a cross-speciality, multi-centre, UK perspectivePuja Mehta, Rachel K Hoyles, Harsha Gunawardena, et al.
The Lancet. Respiratory Medicine|February 22, 2021
Delayed-onset myocarditis following COVID-19Retesh Bajaj, Hannah C Sinclair, Kush Patel, et al.
Rheumatology (Oxford, England)|December 1, 2023
Antibody predictors of mortality and lung function trends in myositis spectrum interstitial lung diseaseJennifer R Hannah, Alexandra Lawrence, Jennifer Martinovic, et al.
The Lancet. Respiratory Medicine|March 30, 2020
The role of CT in case ascertainment and management of COVID-19 pneumonia in the UK: insights from high-incidence regionsFelix Chua, Darius Armstrong-James, Sujal R Desai, et al.
Pageof 2